Navigation Links
Scientists identify proteins that help bacteria put up a fight
Date:2/25/2008

COLUMBUS, Ohio Scientists have identified the role of two proteins that contribute to disease-causing bacteria cells versatility in resisting certain classes of antibiotics.

The finding is a step toward development of drug therapies that could target bacterial resistance at its cellular source. Before researchers can design such drugs, they must understand all of the activities at play in the conflict between bacteria and the agents that kill them.

This finding by Ohio State University microbiologists extends the understanding of how bacteria cells resist antibiotics through the activities of two genetically distinct forms of what are called MprFs, or multiple peptide resistance factors. The proteins they studied are MprF1 and MprF2.

These proteins were found to be key to the mechanism allowing bacteria cells to change the electrical charge of their membrane, which is how the cells develop their resistance to certain antimicrobial agents and, more generally, how they adapt their membrane to new environmental conditions, such as those provided by their host organism.

Both of these proteins are potentially very good drug targets because in theory, if you can target them and inhibit their action, you can make bacteria strains more susceptible to existing antibiotics, said Michael Ibba, associate professor of microbiology at Ohio State and a coauthor of the study.

The findings are described online in this weeks issue of Proceedings of the National Academy of Sciences.

Scientists have already observed that the cell membranes of many disease-causing bacteria develop resistance by changing their electrical charge from negative to positive. Many antibiotics work because they carry a positive charge that attracts them to negatively charged bacteria cells. The opposite charges allow antibiotics to penetrate and kill bacteria. But by changing their naturally occurring negative charge to positive, some bacteria cell
'/>"/>

Contact: Michael Ibba
Ibba.1@osu.edu
614-292-2120
Ohio State University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. CSHL scientists discover new details of a gene-regulatory network governing metabolism
2. Scientists make first map of emerging-disease hotpsots
3. Scientists shed light on long-distance signaling in developing neurons
4. Scientists explore consciousness
5. Scientists using laser light to detect potential diseases via breath samples, says new study
6. Scientists move towards stem cell therapy trials to mend shattered bones
7. U-M scientists develop tool to probe role of oxidative stress in aging, disease
8. Scientists Show Stem Cells Dont Cause Cancer
9. Microbial cheaters help scientists ID social genes
10. Scientists solve structure of gene regulator that plays key role in cancer
11. VEGF Neutralization Can Damage Brain Vessels, Say Schepens Eye Research Institute Scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...heoretical ,anti-cloak, could bring objects out of...ews) -- Just in case someone develops a cloak of i... know how to uncloak the objects it hides. , Ac...certain materials underneath an invisibility cloak..., Researchers at Shanghai Jiao Tong University i...
(Date:9/5/2008).... 5 /PRNewswire/ -- Arthrosurface, Inc.,( http://w...sive joint,resurfacing systems, announced that it ...ts pivotal investigation for its line of focal kne... are no outstanding safety,concerns" with the devi...ce has been evaluating the safety and efficacy of ...
(Date:9/5/2008)...ept. 5 /PRNewswire/ -- Tonight is a momentous,occa...tainment industry,executives, celebrities and prom...acy join forces to Stand Up to Cancer. This collab...p.m. to 9:00 p.m. ET on the three,networks -- ABC,...o elevate,the discussion about cancer and the need...
(Date:9/5/2008)...ewswire/ -- EthicAd, a nonprofit organization,devo...ucation, announces,the launch of a new FDA Web sit...tand direct-to-consumer (DTC) advertising of presc...scription Drug Advertising," is,hosted by the FDA,...developed by the FDA in partnership with EthicAd. ...
Breaking Medicine News(10 mins):Health News:Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage 2Health News:The Leukemia & Lymphoma Society: Standing Up to Cancer for 60 Years 2Health News:Prescription Drug Advertising Subject of New FDA Web Site for Consumers 2
...ple with heart disease to travel by air? For the s...idence on // issues involving air travel for heart... security devices on implantable automatic defibri...reening, and the potential for in-flight deep vein...
...focused on depression in elderly people living in ...s or nursing homes found that // depression and it...many elderly people . The study, involved 250 part...At the start of the study, researchers determined ...
...ey may have found a way to diagnose melancholic de...hem to observe // levels of certain substances in...m of depression marked by insomnia, loss of appeti... study show low levels of the inhibitory transmitt...
...roup of diseases that affect the lungs, including ...rized by permanent // lung damage and irreversible...d, the airways become inflamed, causing airflow ob...e to the lungs is not thought to be permanent. Plu...
Other Medicine News:
(Date:9/5/2008)...W.Va., Sept. 5 /PRNewswire-USNewswire/ -- A team o...n that U.S. immigrants from,India and Pakistan tak...ng,their risks of prostate cancer among male immig...ancer and prostate cancer develop due to many reas...a major role in these cancers,",said Jame Abraham,...
(Date:9/4/2008)...alif., Sept. 4 /- BioForm M... the pivotal clinical study of,Polidocanol, conduc...sche,Fabrik KREUSSLER & Co. GmbH (Kreussler), succ...en submitted to FDA as part of a New Drug Applicat..., named the EASI (Efficacy and safety of,Aethoxysk...
(Date:9/4/2008)...Ala., Sept. 4 /- Southern Research In...es of Health (NIH) has selected,the organization t...ies,Probe Production Center Network (MLPCN). The M...t of the Molecular Libraries Program which is,desi...nowledge of the human,genome and validate future t...
(Date:9/4/2008)...demonstrates potent antiviral activity and favorab... CAMBRIDGE, Mass., Sept. 4 /PRNewswire-FirstCall/... a biopharmaceutical company engaged,in the discov...human viral,and other infectious diseases, today a...t study evaluating IDX899, a non-nucleoside revers...
Breaking Medicine Technology:Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Six Finalists Announced for 2008 Insight Award for Customer Advocacy in Financial Services 14164 1ESFs European ice core project EPICA receives prestigious Descartes Prize 2477 1ESFs European ice core project EPICA receives prestigious Descartes Prize 2477 2ESFs European ice core project EPICA receives prestigious Descartes Prize 2477 3Gene Hunters Fine Tune Marker for Common Obesity Gene 1509 1Gene Hunters Fine Tune Marker for Common Obesity Gene 1509 2Gene Hunters Fine Tune Marker for Common Obesity Gene 1509 3Caring com Joins Entrepreneurs Foundation as 200th Member 14153 1Caring com Joins Entrepreneurs Foundation as 200th Member 14153 2
...une 14, 2007 /PRNewswire-FirstCall/ Haemacure,Corp...cs company,today announced the preliminary findin...scards. , Preliminary findings confirm the presenc...tions in significant worldwide,markets, including ...hese findings take on a strategic significance for...
...(BUSINESS WIRE)--Jun 15, 2007 - Next Safety,Inc. ...omise to,revolutionize pulmonary drug delivery. Th...d air to deliver medications deep into the,pulmona... delivery,systems because it rapidly administers a...viously unrealized efficiencies. The,delivery tech...
Other Medicine Technology:Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 2Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 3Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 4Next Safety, Inc.'s Innovative Drug Delivery System Will Replace,Cigarettes and Significantly Advance Pulmonary Medication Delivery 2
100cc silicone evacuator with hubless flat drain and trocar
Used following open gallbladder procedure to drain bile. Often attached to Bard bile bag.
Silicone Flat Hubless Drains
Hubbed drains are made of translucent silicone and include a full-length X-ray opaque stripe.
Medicine Products: